メインコンテンツに移動

RNIV charges account for big chunk of Swiss banks’ capital

At UBS, 37.5% of its market risk capital requirement was for risks-not-in-VAR

Trading exposures that cannot be measured accurately using value-at-risk models make up more than one-third of UBS’s market risk capital charge, and almost as large a share at Credit Suisse.

Risks-not-in-VAR (RNIV) accounted for $329 million of the Swiss bank’s total market risk capital requirement of $878 million (37.5%) as of the second quarter of this year.

Its Swiss rival, Credit Suisse, had

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here